与免疫检查点抑制性炎相关的临床特征:单中心临床病例系列
Ramya Muddasani1, Neel Talwar1, Isa Mambetsariev1
1Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010, USA.
Cancer immunology, immunotherapy : CII
|August 6, 2024
概括
免疫检查点抑制剂引起的急性损伤 (AKI) 呈现变化,通常与其他药物有关. 类固醇治疗导致大多数患者的AKI解决,突出了个性化管理策略的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 免疫检查点抑制剂 (ICI) 与急性损伤 (AKI) 有关.
- 这项研究侧重于肺腺癌患者在ICI治疗期间发展AKI.
研究的目的:
- 在接受ICI的患者中描述AKI的临床表现,机制和结果.
- 探索与ICI诱导的AKI相关的潜在基因组因素.
主要方法:
- 对六名ICI相关AKI患者的回顾性分析.
- 脏活检用于AKI机制的分类.
- 瘤组织的综合基因组分析 (CGP).
主要成果:
- AKI模式包括急性间歇性炎和急性管道亡.
- 同时服用的药物被确定为导致因素.
- 在大多数患者中,类固醇治疗导致AKI解决.
- 基因组分析揭示了突变 (例如,EXON 20插入,NF1,TP53) 和高PD-L1表达在某些情况下.
- 在一小部分患者中观察到蛋白尿和球病变 (最小变化疾病,FSGS).
结论:
- 由ICI引起的AKI具有可变的表现,需要个性化治疗.
- 需要进一步的研究来确定用于风险分层和管理指导的生物标志物.
相关概念视频
Acute Pyelonephritis I: Introduction
1.5K
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.5K
Nephrotic Syndrome I : Introduction
1.2K
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Acute Kidney Injury III: Clinical Manifestations
1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K


